- Category
- Medium (2024-25)
- Udyam number
- UDYAM-AP-08-0028966

Hatri Pharma Private Limited
About Hatri Pharma Private Limited
Data last updated:
Hatri Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 July 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TS2010PTC205106. Its GSTIN is 37AACCH4672C1ZQ (Andhra Pradesh).
The company has an authorised share capital of ₹27 Cr and a paid-up capital of ₹23.73 Cr. It is led by directors including Sumalatha Ambarapu and Rebala Rupakala.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹71.68 Lakh, a decline of 93% compared to the previous year. For the same year it recorded a net loss of ₹4.33 Cr and EBITDA of -₹58.15 Lakh (EBITDA margin -81.1%).
As per MCA filings, the company has open charges of ₹13.5 Cr on record. Court records list 13 cases involving the company, including 1 filed by the company and 12 filed against it; 12 cases are pending.
Hatri Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-08-0028966). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Hatri Pharma has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24232TS2010PTC205106, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TS2010PTC205106 | Current |
| U24232TG2010PTC069596 | Previous |
| U24232AP2010PTC116314 | Previous |
| U24232AP2010PTC069596 | Previous |
Recognitions & Rankings of Hatri Pharma
Contact details
Hatri Pharma Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressPlot No.16 2nd Floor, Durga Shakti Peetam Prashanthi Nagar, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hatri Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hatri Pharma Private Limited, buy the company report.
Financials of Hatri Pharma Private Limited
FY 2025 filings availableHatri Pharma Private Limited reported revenue of ₹71.68 Lakh (down 93% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 93% in the latest year. EBITDA fell 214% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹58.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.33 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -81.1% | ||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hatri Pharma Private Limited, buy the company report.
Board of directors of Hatri Pharma Private Limited
Hatri Pharma has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumalatha Ambarapu | Director | 09 Aug 2023 | 3 Years 3 Months | Current |
| Rebala Rupakala | Director | 30 Oct 2017 | 9 Years 0 Months | Current |
| Mohan Reddy Enaganuri | Director | 21 Jul 2010 | 16 Years 3 Months | Current |
Peer comparison
Hatri Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alder Research Chemicals Private Limited | ₹77.52 Lakh (FY 2024) | -20.0% | Khammam, Telangana, India | |||
| Mansfield Pharma Private Limited | ₹77.51 Lakh (FY 2024) | 314.0% | Hyderabad, Telangana, India | |||
| Auronext Pharma Private Limited | ₹75.75 Lakh (FY 2023) | 23.0% | Hyderabad, Telangana, India | |||
| Hatri Pharma Private Limitedthis company | ₹71.68 Lakh (FY 2025) | -₹4.33 Cr | -93.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Hatri Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Sep 2020 | 100378112 | Others | ₹13.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Hatri Pharma Private Limited has 13 court cases on record: 1 filed by Hatri Pharma, 12 filed against it. 12 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 12 | 12 | 12 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, MYSURU, Karnataka | Court case (Com.O.S.) | Filed against the company by an individual | Pending |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed against the company by an individual | Pending |
| District court, Nellore, Andhra Pradesh | Criminal complaint | Filed against the company by an individual | Pending |
| District court, Nellore, Andhra Pradesh | Criminal complaint | Filed against the company by an individual | Pending |
| District court, Nellore, Andhra Pradesh | Civil suit | Filed against the company by an individual | Pending |
To see the full case history of Hatri Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Hatri Pharma Private Limited was last rated by Crisil on 09 Apr 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 09 Apr 2020 |
To see the full credit ratings and regulatory alerts of Hatri Pharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hatri Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hatri Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AACCH4672C1ZQ | Andhra Pradesh | Active | 22 Jun 2019 |
To see the full GST registrations and return filing status of Hatri Pharma Private Limited, buy the company report.
Recent activity
Hatri Pharma Private Limited has 10 board changes on record since 2010: 3 appointments and 7 cessations. The latest: Archana Guddeti ceased to be Director on 03 Jun 2025.
2 earlier events are in the company report.
Frequently asked questions
Hatri Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 July 2010 (16+ years old) and is registered under CIN U24232TS2010PTC205106.
Hatri Pharma has 3 current directors:
- Sumalatha Ambarapu - Director
- Rebala Rupakala - Director
- Mohan Reddy Enaganuri - Director
The latest financial statements of Hatri Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Hatri Pharma is 37AACCH4672C1ZQ, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Hatri Pharma is U24232TS2010PTC205106. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hatri Pharma has 13 court cases on record: 1 filed by the company and 12 filed against it. 12 are pending. Most are in the district courts.
Hatri Pharma was incorporated on 21 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Hatri Pharma by revenue are Alder Research Chemicals Private Limited, Mansfield Pharma Private Limited, Auronext Pharma Private Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Archana Guddeti ceased to be Director on 03 Jun 2025. Dayakar Reddy Vangala ceased to be Director on 20 May 2025. Ravindra Reddy Paidimarla ceased to be Director on 20 May 2025. Hatri Pharma has 10 board changes on record in total.
Yes, Hatri Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-AP-08-0028966).
The registered office of Hatri Pharma is at Plot No.16 2nd Floor, Durga Shakti Peetam Prashanthi Nagar, Hyderabad, Telangana, India – 500072.

